search
Back to results

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Primary Purpose

Hidradenitis Suppurativa

Status
Recruiting
Phase
Phase 2
Locations
International
Study Type
Interventional
Intervention
Spesolimab Formulation 1
Spesolimab Formulation 2
Placebo matching Spesolimab Formulation 1
Placebo matching Spesolimab Formulation 2
Sponsored by
Boehringer Ingelheim
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hidradenitis Suppurativa

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Of full age of consent at screening. Signed and dated written informed consent in accordance with International Council on Harmonisation-Good clinical practice (ICH-GCP) and local legislation prior to admission to the trial. Moderate to severe HS. HS lesions in at least 2 distinct anatomic areas. Biologic naive or Tumor Necrosis Factor inhibitor (TNFi)-exposed for HS. For biologic naïve, inadequate response to an adequate course of appropriate oral antibiotics for treatment of HS. Total AN count of greater than or equal to 5. Total dT count of at least 1 at Baseline visit. Further criteria apply. Exclusion Criteria: Participants who must or wish to continue the intake of restricted medications or any drug considered likely to interfere with the safe conduct of the trial. Prior exposure to any immunosuppressive biologic other than TNFi for HS. Prior exposure to Interleukin 36 receptor (IL-36R) inhibitors including spesolimab. Treated with any investigational device or investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives of the drug, whichever is longer. Women who are pregnant, nursing, or who plan to become pregnant while in the trial. Participants with history of allergy/hypersensitivity to the systemically administered trial medication agent or its excipients. Participants with a transplanted organ (with exception of a corneal transplant >12 weeks prior to screening) or who has ever received stem cell therapy (e.g., Remestemcel-L). Participants with any documented active or suspected malignancy or history of malignancy within 5 years prior to the screening visit, except appropriately treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or in situ carcinoma of uterine cervix. Further criteria apply.

Sites / Locations

  • First QC DermatologyRecruiting
  • Dermatology Research AssociatesRecruiting
  • Integrative Skin Science and ResearchRecruiting
  • Clinical Trials Research InstituteRecruiting
  • ForCare Clinical Research, Inc.Recruiting
  • Olympian Clinical ResearchRecruiting
  • Dawes Fretzin Clinical Research Group, LLCRecruiting
  • Skin Specialists, P.C.Recruiting
  • Medical University of South CarolinaRecruiting
  • Palmetto Clinical Trial ServicesRecruiting
  • Center for Clinical StudiesRecruiting
  • Progressive Clinical ResearchRecruiting
  • STAT ResearchRecruiting
  • Hospital Italiano de Buenos AiresRecruiting
  • Hospital AlemánRecruiting
  • Centro de Investigaciones Médicas Mar del PlataRecruiting
  • Instituto de Especialidades de la Salud RosarioRecruiting
  • Sanatorio 9 de Julio S.A.Recruiting
  • Holdsworth House Medical PracticeRecruiting
  • Westmead HospitalRecruiting
  • Alfred HospitalRecruiting
  • Brussels - UNIV Saint-LucRecruiting
  • Centre Hospitalier Universitaire de LiègeRecruiting
  • Medical Center "Cordis"Recruiting
  • ASMC-IPSMC-skin and Veneral DiseasesRecruiting
  • Medical Military Academy MHAT SofiaRecruiting
  • MHAT Prof Stoyan Kirkovich ADRecruiting
  • Alberta DermaSurgery CentreRecruiting
  • SimcoDerm Medical and Surgical Dermatology CentreRecruiting
  • Guelph Dermatology ResearchRecruiting
  • Dr. S. K. Siddha Medicine Professional CorporationRecruiting
  • York Dermatology Clinic and Research CentreRecruiting
  • Centro Internacional de Estudios Clínicos (CIEC)Recruiting
  • Clínica Dermacross S.A.Recruiting
  • Bispebjerg og Frederiksberg HospitalRecruiting
  • Sjællands UniversitetshospitalRecruiting
  • Suomen Terveystalo oy TampereRecruiting
  • HOP Privé AntonyRecruiting
  • HOP Edouard HerriotRecruiting
  • HOP TimoneRecruiting
  • HOP l'ArchetRecruiting
  • HOP Saint-LouisRecruiting
  • HOP la MilétrieRecruiting
  • HOP PontchaillouRecruiting
  • Fachklinik Bad BentheimRecruiting
  • Charité - Universitätsmedizin BerlinRecruiting
  • Katholisches Klinikum Bochum gGmbHRecruiting
  • Universitätsmedizin Göttingen, Georg-August-UniversitätRecruiting
  • Hautmedizin SaarRecruiting
  • Klinikum Oldenburg AöRRecruiting
  • Haemek Medical CenterRecruiting
  • Sheba MCRecruiting
  • Pol. Universitario Tor VergataRecruiting
  • Istituto Dermopatico Dell'Immacolata - IDI - IRCCSRecruiting
  • Japan Community Healthcare Organization Chukyo HospitalRecruiting
  • Nagoya City University HospitalRecruiting
  • Fujita Health University HospitalRecruiting
  • Fukuoka University HospitalRecruiting
  • Kurume University HospitalRecruiting
  • Ogaki Municipal HospitalRecruiting
  • Meiwa HospitalRecruiting
  • University of Tsukuba HospitalRecruiting
  • Tohoku University HospitalRecruiting
  • Okayama University HospitalRecruiting
  • National Hospital Organization Okayama Medical CenterRecruiting
  • University of the Ryukyus HospitalRecruiting
  • Kansai Medical University HospitalRecruiting
  • Shiga University of Medical Science HospitalRecruiting
  • Dokkyo Medical University HospitalRecruiting
  • The University of Tokyo HospitalRecruiting
  • Nihon University Itabashi HospitalRecruiting
  • Tokyo Medical University HospitalRecruiting
  • Korea University Anam HospitalRecruiting
  • Seoul National University HospitalRecruiting
  • Hallym University Kangnam Sacred Heart HospitalRecruiting
  • Hospital of Lithuanian University of Health Sciences Kauno KlinikosRecruiting
  • Vilnius University Hospital, SantariskiuRecruiting
  • Hospital Pulau PinangRecruiting
  • Hospital Sultanah AminahRecruiting
  • Hospital Sultan IsmailRecruiting
  • Hospital Raja Perempuan Zainab II, Kota BharuRecruiting
  • Hospital Kuala LumpurRecruiting
  • Hospital Sultanah Nur ZahirahRecruiting
  • Sarawak General HospitalRecruiting
  • Sunway Medical CentreRecruiting
  • Universitair Medisch Centrum GroningenRecruiting
  • Waikato HospitalRecruiting
  • Center for Skin Research, Testing and Product DevelopmentRecruiting
  • Non-Public Health Care Facility LABDERMRecruiting
  • High-Med Specialist Clinic, WarsawRecruiting
  • National Medical Institute MSWiARecruiting
  • Provita ClinicRecruiting
  • RoyaldermRecruiting
  • Centrum Zdrowia WroMedicaRecruiting
  • National University HospitalRecruiting
  • DOST sro - Sanatorium-Type Dermatovenereological DepartmentRecruiting
  • TASK Applied ScienceRecruiting
  • Hospital Santa Creu i Sant PauRecruiting
  • Hospital Universitario Reina SofíaRecruiting
  • Hospital Universitario San CecilioRecruiting
  • Hospital General de GranollersRecruiting
  • Hospital General Universitario Gregorio MarañónRecruiting
  • Hospital Universitario 12 de OctubreRecruiting
  • Hospital de ManisesRecruiting
  • Hospital Universitario de SalamancaRecruiting
  • Complexo Hospitalario Universitario De SantiagoRecruiting
  • Hospital Miguel ServetRecruiting
  • University Hospital Bern/Inselspital BernRecruiting
  • Hôpitaux Universitaires Genève (HUG) Dermatologie et vénéréologieRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Experimental

Placebo Comparator

Arm Label

Part I: Low dose group

Part I: Medium dose group

Part I: High dose group

Part I: Placebo group

Part II: Active (treatment) group

Part II: Placebo group

Arm Description

Outcomes

Primary Outcome Measures

Part 1: Percent change from baseline in Draining fistula/tunnel (dT) count at Week 8

Secondary Outcome Measures

Part 1: Percent change from baseline in dT count at Week 16 (part 1)
Part 1: Absolute change from baseline in International hidradenitis suppurativa severity score system (IHS4) value at Week 8
The IHS4 score is arrived at by the number of nodules (multiplied by 1) plus the number of abscesses (multiplied by 2) plus the number of draining tunnels (multiplied by 4). A total score of 3 or less signifies mild, 4-10 signifies moderate and 11 or higher signifies severe disease.
Part 1: Absolute change from baseline in IHS4 value at Week 16
Part 1: Occurrence of treatment emergent adverse events (TEAEs)

Full Information

First Posted
April 6, 2023
Last Updated
October 17, 2023
Sponsor
Boehringer Ingelheim
search

1. Study Identification

Unique Protocol Identification Number
NCT05819398
Brief Title
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
Official Title
Randomised, Double-blind, Placebo-controlled, Phase IIb/Phase III Study to Evaluate the Efficacy and Safety of Spesolimab in Patients With Moderate to Severe Hidradenitis Suppurativa. Lunsayil 1.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 10, 2023 (Actual)
Primary Completion Date
November 7, 2024 (Anticipated)
Study Completion Date
September 21, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boehringer Ingelheim

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is open to adults with moderate to severe hidradenitis suppurativa (HS). The purpose of this study is to find out whether a medicine called spesolimab helps people with HS. People who have previously taken specific medicines such as immunosuppressive biologics other than Tumor necrosis factor (TNF) inhibitors cannot take part. This study has 2 parts. In Part 1, participants are divided into 4 groups of almost equal size. 3 groups get different doses of spesolimab, 1 group gets placebo. All participants get injections into a vein or under the skin. Placebo injections look like spesolimab injections, but do not contain any medicine. Every participant has an equal chance of being in each group. In the beginning, participants get the study medicine every week and later every 2 weeks. After 4 months, participants in the placebo group switch to spesolimab treatment. In Part 2, participants are divided into 2 groups. One group gets a suitable dose of spesolimab that was found in Part 1 of the study. The other group gets placebo. After 4 months, participants in the placebo group switch to spesolimab treatment. Participants join only one of the two parts. They are in the study for about 1 year. During this time, they visit the study site in the beginning every week and later every 2 weeks. Some of the visits can be done at the participant's home instead of the study site. The doctors regularly check participants' HS symptoms. The results are compared between the groups to see whether spesolimab works. The doctors also regularly check participants' general health and take note of any unwanted effects.
Detailed Description
Main endpoints for Part 2 will be supported by Part1 results available at time of primary analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hidradenitis Suppurativa

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Part I: Low dose group
Arm Type
Experimental
Arm Title
Part I: Medium dose group
Arm Type
Experimental
Arm Title
Part I: High dose group
Arm Type
Experimental
Arm Title
Part I: Placebo group
Arm Type
Placebo Comparator
Arm Title
Part II: Active (treatment) group
Arm Type
Experimental
Arm Title
Part II: Placebo group
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Spesolimab Formulation 1
Other Intervention Name(s)
Spevigo®
Intervention Description
Spesolimab Formulation 1
Intervention Type
Drug
Intervention Name(s)
Spesolimab Formulation 2
Other Intervention Name(s)
Spevigo®
Intervention Description
Spesolimab Formulation 2
Intervention Type
Drug
Intervention Name(s)
Placebo matching Spesolimab Formulation 1
Intervention Description
Placebo matching Spesolimab Formulation 1
Intervention Type
Drug
Intervention Name(s)
Placebo matching Spesolimab Formulation 2
Intervention Description
Placebo matching Spesolimab Formulation 2
Primary Outcome Measure Information:
Title
Part 1: Percent change from baseline in Draining fistula/tunnel (dT) count at Week 8
Time Frame
At baseline and at week 8
Secondary Outcome Measure Information:
Title
Part 1: Percent change from baseline in dT count at Week 16 (part 1)
Time Frame
At baseline and at week 16
Title
Part 1: Absolute change from baseline in International hidradenitis suppurativa severity score system (IHS4) value at Week 8
Description
The IHS4 score is arrived at by the number of nodules (multiplied by 1) plus the number of abscesses (multiplied by 2) plus the number of draining tunnels (multiplied by 4). A total score of 3 or less signifies mild, 4-10 signifies moderate and 11 or higher signifies severe disease.
Time Frame
At baseline and at week 8
Title
Part 1: Absolute change from baseline in IHS4 value at Week 16
Time Frame
At baseline and at week 16
Title
Part 1: Occurrence of treatment emergent adverse events (TEAEs)
Time Frame
up to 64 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Of full age of consent at screening. Signed and dated written informed consent in accordance with International Council on Harmonisation-Good clinical practice (ICH-GCP) and local legislation prior to admission to the trial. Moderate to severe HS. HS lesions in at least 2 distinct anatomic areas. Biologic naive or Tumor Necrosis Factor inhibitor (TNFi)-exposed for HS. For biologic naïve, inadequate response to an adequate course of appropriate oral antibiotics for treatment of HS. Total AN count of greater than or equal to 5. Total dT count of at least 1 at Baseline visit. Further criteria apply. Exclusion Criteria: Participants who must or wish to continue the intake of restricted medications or any drug considered likely to interfere with the safe conduct of the trial. Prior exposure to any immunosuppressive biologic other than TNFi for HS. Prior exposure to Interleukin 36 receptor (IL-36R) inhibitors including spesolimab. Treated with any investigational device or investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives of the drug, whichever is longer. Women who are pregnant, nursing, or who plan to become pregnant while in the trial. Participants with history of allergy/hypersensitivity to the systemically administered trial medication agent or its excipients. Participants with a transplanted organ (with exception of a corneal transplant >12 weeks prior to screening) or who has ever received stem cell therapy (e.g., Remestemcel-L). Participants with any documented active or suspected malignancy or history of malignancy within 5 years prior to the screening visit, except appropriately treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or in situ carcinoma of uterine cervix. Further criteria apply.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Boehringer Ingelheim
Phone
1-800-243-0127
Email
clintriage.rdg@boehringer-ingelheim.com
Facility Information:
Facility Name
First QC Dermatology
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Dermatology Research Associates
City
Los Angeles
State/Province
California
ZIP/Postal Code
90045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Integrative Skin Science and Research
City
Sacramento
State/Province
California
ZIP/Postal Code
95815
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Clinical Trials Research Institute
City
Thousand Oaks
State/Province
California
ZIP/Postal Code
91320
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
ForCare Clinical Research, Inc.
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Olympian Clinical Research
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Dawes Fretzin Clinical Research Group, LLC
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46250
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Skin Specialists, P.C.
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Palmetto Clinical Trial Services
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Center for Clinical Studies
City
Houston
State/Province
Texas
ZIP/Postal Code
77004
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
Progressive Clinical Research
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78213
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
833-602-2368
Email
unitedstates@bitrialsupport.com
Facility Name
STAT Research
City
Caba
ZIP/Postal Code
C1023AAB
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Hospital Italiano de Buenos Aires
City
Caba
ZIP/Postal Code
C1056AB
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Hospital Alemán
City
Capital Federal
ZIP/Postal Code
C1118AAT
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Centro de Investigaciones Médicas Mar del Plata
City
Mar del Plata
ZIP/Postal Code
7600
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Instituto de Especialidades de la Salud Rosario
City
Rosario
ZIP/Postal Code
2000
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Sanatorio 9 de Julio S.A.
City
San Miguel de Tucumán
ZIP/Postal Code
4000
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08002667801
Email
argentina@bitrialsupport.com
Facility Name
Holdsworth House Medical Practice
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2010
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800271035
Email
australia@bitrialsupport.com
Facility Name
Westmead Hospital
City
Westmead
State/Province
New South Wales
ZIP/Postal Code
2145
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800271035
Email
australia@bitrialsupport.com
Facility Name
Alfred Hospital
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3004
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800271035
Email
australia@bitrialsupport.com
Facility Name
Brussels - UNIV Saint-Luc
City
Bruxelles
ZIP/Postal Code
1200
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
080049616
Email
belgique@bitrialsupport.com
Facility Name
Centre Hospitalier Universitaire de Liège
City
Liège
ZIP/Postal Code
4000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
080049616
Email
belgique@bitrialsupport.com
Facility Name
Medical Center "Cordis"
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
024903378
Email
balgariya@bitrialsupport.com
Facility Name
ASMC-IPSMC-skin and Veneral Diseases
City
Sofia
ZIP/Postal Code
1407
Country
Bulgaria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
024903378
Email
balgariya@bitrialsupport.com
Facility Name
Medical Military Academy MHAT Sofia
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
024903378
Email
balgariya@bitrialsupport.com
Facility Name
MHAT Prof Stoyan Kirkovich AD
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
024903378
Email
balgariya@bitrialsupport.com
Facility Name
Alberta DermaSurgery Centre
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 1C3
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
18336022346
Email
canada@bitrialsupport.com
Facility Name
SimcoDerm Medical and Surgical Dermatology Centre
City
Barrie
State/Province
Ontario
ZIP/Postal Code
L4M 7G1
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
18336022346
Email
canada@bitrialsupport.com
Facility Name
Guelph Dermatology Research
City
Guelph
State/Province
Ontario
ZIP/Postal Code
N1L 0B7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
18336022346
Email
canada@bitrialsupport.com
Facility Name
Dr. S. K. Siddha Medicine Professional Corporation
City
Newmarket
State/Province
Ontario
ZIP/Postal Code
L3Y 5G8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
18336022346
Email
canada@bitrialsupport.com
Facility Name
York Dermatology Clinic and Research Centre
City
Richmond Hill
State/Province
Ontario
ZIP/Postal Code
L4C 9M7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
18336022346
Email
canada@bitrialsupport.com
Facility Name
Centro Internacional de Estudios Clínicos (CIEC)
City
Comuna De Recoleta
ZIP/Postal Code
8420383
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
800392345
Email
chile@bitrialsupport.com
Facility Name
Clínica Dermacross S.A.
City
Vitacura
ZIP/Postal Code
7640881
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
800392345
Email
chile@bitrialsupport.com
Facility Name
Bispebjerg og Frederiksberg Hospital
City
København NV
ZIP/Postal Code
2400
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
80711822
Email
danmark@bitrialsupport.com
Facility Name
Sjællands Universitetshospital
City
Roskilde
ZIP/Postal Code
4000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
80711822
Email
danmark@bitrialsupport.com
Facility Name
Suomen Terveystalo oy Tampere
City
Tampere
ZIP/Postal Code
33100
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800918118
Email
suomi@bitrialsupport.com
Facility Name
HOP Privé Antony
City
Antony
ZIP/Postal Code
92160
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP Edouard Herriot
City
Lyon
ZIP/Postal Code
69437
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP Timone
City
Marseille
ZIP/Postal Code
13385
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP l'Archet
City
Nice
ZIP/Postal Code
06202
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP Saint-Louis
City
Paris
ZIP/Postal Code
75010
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP la Milétrie
City
Poitiers
ZIP/Postal Code
86000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
HOP Pontchaillou
City
Rennes
ZIP/Postal Code
35033
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0805102354
Email
france@bitrialsupport.com
Facility Name
Fachklinik Bad Bentheim
City
Bad Bentheim
ZIP/Postal Code
48455
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Charité - Universitätsmedizin Berlin
City
Berlin
ZIP/Postal Code
10117
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Katholisches Klinikum Bochum gGmbH
City
Bochum
ZIP/Postal Code
44791
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Universitätsmedizin Göttingen, Georg-August-Universität
City
Göttingen
ZIP/Postal Code
37075
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Hautmedizin Saar
City
Merzig
ZIP/Postal Code
66663
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Klinikum Oldenburg AöR
City
Oldenburg
ZIP/Postal Code
26133
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08007234742
Email
deutschland@bitrialsupport.com
Facility Name
Haemek Medical Center
City
Afula
ZIP/Postal Code
1834111
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1809388162
Email
israel@bitrialsupport.com
Facility Name
Sheba MC
City
Ramat Gan
ZIP/Postal Code
52621
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1809388162
Email
israel@bitrialsupport.com
Facility Name
Pol. Universitario Tor Vergata
City
Roma
ZIP/Postal Code
00133
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
800977373
Email
italia@bitrialsupport.com
Facility Name
Istituto Dermopatico Dell'Immacolata - IDI - IRCCS
City
Roma
ZIP/Postal Code
00167
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
800977373
Email
italia@bitrialsupport.com
Facility Name
Japan Community Healthcare Organization Chukyo Hospital
City
Aichi, Nagoya
ZIP/Postal Code
457-8510
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Nagoya City University Hospital
City
Aichi, Nagoya
ZIP/Postal Code
467-8602
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Fujita Health University Hospital
City
Aichi, Toyoake
ZIP/Postal Code
470-1192
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Fukuoka University Hospital
City
Fukuoka, Fukuoka
ZIP/Postal Code
814-0180
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Kurume University Hospital
City
Fukuoka, Kurume
ZIP/Postal Code
830-0011
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Ogaki Municipal Hospital
City
Gifu, Ogaki
ZIP/Postal Code
503-8502
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Meiwa Hospital
City
Hyogo, Nishinomiya
ZIP/Postal Code
663-8186
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
University of Tsukuba Hospital
City
Ibaraki, Tsukuba
ZIP/Postal Code
305-8576
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Tohoku University Hospital
City
Miyagi, Sendai
ZIP/Postal Code
980-8574
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Okayama University Hospital
City
Okayama, Okayama
ZIP/Postal Code
700-8558
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
National Hospital Organization Okayama Medical Center
City
Okayama, Okayama
ZIP/Postal Code
701-1192
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
University of the Ryukyus Hospital
City
Okinawa, Nakagami-gun
ZIP/Postal Code
903-0215
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Kansai Medical University Hospital
City
Osaka, Hirakata
ZIP/Postal Code
573-1191
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Shiga University of Medical Science Hospital
City
Shiga, Otsu
ZIP/Postal Code
520-2192
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Dokkyo Medical University Hospital
City
Tochigi, Shimotsuga-gun
ZIP/Postal Code
321-0293
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
The University of Tokyo Hospital
City
Tokyo, Bunkyo-ku
ZIP/Postal Code
113-8655
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Nihon University Itabashi Hospital
City
Tokyo, Itabashi-ku
ZIP/Postal Code
173-8610
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Tokyo Medical University Hospital
City
Tokyo, Shinjuku-ku
ZIP/Postal Code
160-0023
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0120201230
Email
nippon@bitrialsupport.com
Facility Name
Korea University Anam Hospital
City
Seoul
ZIP/Postal Code
02841
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0808802084
Email
namhan@bitrialsupport.com
Facility Name
Seoul National University Hospital
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0808802084
Email
namhan@bitrialsupport.com
Facility Name
Hallym University Kangnam Sacred Heart Hospital
City
Seoul
ZIP/Postal Code
07441
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0808802084
Email
namhan@bitrialsupport.com
Facility Name
Hospital of Lithuanian University of Health Sciences Kauno Klinikos
City
Kaunas
ZIP/Postal Code
50161
Country
Lithuania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
80080099
Email
lithuania@bitrialsupport.com
Facility Name
Vilnius University Hospital, Santariskiu
City
Vilnius
ZIP/Postal Code
08661
Country
Lithuania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
80080099
Email
lithuania@bitrialsupport.com
Facility Name
Hospital Pulau Pinang
City
Georgetown Pulau Pinang
ZIP/Postal Code
10990
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Hospital Sultanah Aminah
City
Johor Bahru
ZIP/Postal Code
80100
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Hospital Sultan Ismail
City
Johor Bahru
ZIP/Postal Code
81100
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Hospital Raja Perempuan Zainab II, Kota Bharu
City
Kota Bahru
ZIP/Postal Code
15586
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Hospital Kuala Lumpur
City
Kuala Lumpur
ZIP/Postal Code
50586
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Hospital Sultanah Nur Zahirah
City
Kuala Trengganu
ZIP/Postal Code
20400
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Sarawak General Hospital
City
Kuching
ZIP/Postal Code
93586
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Sunway Medical Centre
City
Selangor Darul Ehsan
ZIP/Postal Code
47500
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
1800814353
Email
malaysia@bitrialsupport.com
Facility Name
Universitair Medisch Centrum Groningen
City
Groningen
ZIP/Postal Code
9700 RB
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
08000204613
Email
nederland@bitrialsupport.com
Facility Name
Waikato Hospital
City
Hamilton
ZIP/Postal Code
3204
Country
New Zealand
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800440725
Email
newzealand@bitrialsupport.com
Facility Name
Center for Skin Research, Testing and Product Development
City
Makati City
ZIP/Postal Code
1200
Country
Philippines
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
180084748502
Email
pilipinas@bitrialsupport.com
Facility Name
Non-Public Health Care Facility LABDERM
City
Ossy
ZIP/Postal Code
42624
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
008001218830
Email
polska@bitrialsupport.com
Facility Name
High-Med Specialist Clinic, Warsaw
City
Warsaw
ZIP/Postal Code
01-817
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
008001218830
Email
polska@bitrialsupport.com
Facility Name
National Medical Institute MSWiA
City
Warsaw
ZIP/Postal Code
02-507
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
008001218830
Email
polska@bitrialsupport.com
Facility Name
Provita Clinic
City
Warsaw
ZIP/Postal Code
02-647
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
8001207344
Email
singapore@bitrialsupport.com
Facility Name
Royalderm
City
Warszawa
ZIP/Postal Code
02-962
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
008001218830
Email
polska@bitrialsupport.com
Facility Name
Centrum Zdrowia WroMedica
City
Wroclaw
ZIP/Postal Code
51-685
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
008001218830
Email
polska@bitrialsupport.com
Facility Name
National University Hospital
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800002662
Email
slovensko@bitrialsupport.com
Facility Name
DOST sro - Sanatorium-Type Dermatovenereological Department
City
Svidnik
ZIP/Postal Code
089 01
Country
Slovakia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0809092098
Email
taiwan@bitrialsupport.com
Facility Name
TASK Applied Science
City
Cape Town
ZIP/Postal Code
7530
Country
South Africa
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800988886
Email
southafrica@bitrialsupport.com
Facility Name
Hospital Santa Creu i Sant Pau
City
Barcelona
ZIP/Postal Code
08026
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital Universitario Reina Sofía
City
Córdoba
ZIP/Postal Code
14004
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital Universitario San Cecilio
City
Granada
ZIP/Postal Code
18012
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital General de Granollers
City
Granollers
ZIP/Postal Code
08402
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital General Universitario Gregorio Marañón
City
Madrid
ZIP/Postal Code
28009
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital Universitario 12 de Octubre
City
Madrid
ZIP/Postal Code
28041
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital de Manises
City
Manises
ZIP/Postal Code
46940
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital Universitario de Salamanca
City
Salamanca
ZIP/Postal Code
37007
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Complexo Hospitalario Universitario De Santiago
City
Santiago de Compostela
ZIP/Postal Code
15706
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
Hospital Miguel Servet
City
Zaragoza
ZIP/Postal Code
50009
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
900876092
Email
espana@bitrialsupport.com
Facility Name
University Hospital Bern/Inselspital Bern
City
Bern
ZIP/Postal Code
3010
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800005900
Email
suisse@bitrialsupport.com
Facility Name
Hôpitaux Universitaires Genève (HUG) Dermatologie et vénéréologie
City
Geneve
ZIP/Postal Code
1205
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Phone
0800005900
Email
suisse@bitrialsupport.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Once the criteria in section "Time Frame" are fulfilled, researchers can use the following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms o
IPD Sharing Time Frame
After structured results have been posted, all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.
IPD Sharing Access Criteria
For study documents - upon signing of a 'Document Sharing Agreement'. For study data - 1. after the submission and approval of the research proposal (checks will be performed by the sponsor and/or the independent review panel, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a legal agreement.
IPD Sharing URL
https://www.mystudywindow.com/msw/datasharing
Links:
URL
https://www.mystudywindow.com
Description
Related Info

Learn more about this trial

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

We'll reach out to this number within 24 hrs